Stock Analysis of Artivion Inc (AORT) - Birds Eye View

1W   2W   1M   3M   1Y   2Y   5Y   
Overview
Code AORT
Close 23.81
Change 0.350 / 1.49 %
Volume 147745
Vol Change 35775.00 / 31.95 %
IndustryMedical Devices
SectorHealthcare
AIO Strength Index
Technical StrengthBullish
Growth Index Poor Growth Stock
Value Index Poor Value Stock
Profitability Index Very Low Profitability Stock
Stability Index Very Low Stability Stock


Fundamental View of Artivion Inc


Highs/Lows of Artivion Inc
PeriodOld priceStock ReturnS&P 500 ReturnsHighLowHigh DateLow Date
One Week23.2 2.63 % 1.66 % 24.16523.0215-May-2414-May-24
Two Week21.07 13.00 % 2.46 % 25.513822.7207-May-2408-May-24
One Month20.03 18.87 % 6.86 % 25.513819.3607-May-2401-May-24
Three Month18.7 27.33 % 6.69 % 25.513818.380907-May-2405-Mar-24
Six Months14.12 68.63 % 16.73 % 25.513815.2507-May-2421-Nov-23
One year15.01 58.63 % 26.63 % 25.513812.158207-May-2430-Oct-23
Two year18.84 26.38 % 36.06 % 25.51389.6407-May-2412-Oct-22
Five year29.32 18.79 % 86.89 % 25.51389.6407-May-2412-Oct-22
Ten year8.55 178.48 % 183.43 % 36.058.425-Sep-1802-Jun-14


Technical View of Artivion Inc






Charts of Artivion Inc


Returns of Artivion Inc with Peers
Period / StockAORTAHCOHSKAAVNSSRRK
1 Week2.63%4.11%0.083%2.21%-8.21%
1 Mth18.87%5.89%2.45%8.61%-9.60%
3 Mth27.33%36.60%45.81%4.21%-16.59%
6mth68.63%16.08%81.31%-5.14%6.55%
1 Year58.63%-10.42%31.18%-9.81%53.06%
2 Year26.38%-43.42%-41.81%-26.38%136.67%
5 Years-18.79%-1.49%12.16%-52.21%-39.05%
charts-
View All Together in Chart      Inline           Tile

Compare Fundamentals of Artivion Inc with Peers
Ratio / StockAORTAHCOHSKAAVNSSRRK
PE-105.39-1.91-173.25-15.19-2747.99
P/B3.590.7354.560.7602501.00
ROA-1.24-14.38-1.72-3.65-64.14
ROE-3.41-38.67-2.63-5.01-91.01
Debt To Equity1.111.500.2330.1460.255
Revenue354004 K
12.82 %
3080.20 M
3.69 %
257307 K
1.41 %
817500 K
0.305 %
0
100.00 %
Net Income-30567.00 K
59.27 %
-426980.00 K
715.99 %
-19889.00 K
1632.49 %
-55400.00 K
209.70 %
-158918.00 K
18.15 %


Technicals of Artivion Inc with Peers
Technical / StockAORTAHCOHSKAAVNSSRRK-
ADX29.3521.0453.5322.4214.86
CMF-0.0670.137-0.00350.0255-0.128
MFI69.9456.9478.2780.0449.14
RSI67.3049.9475.4663.1735.91
MACD Abv SignalTrueTrueFalseTrueFalse
Price Above 50 MATrueFalseTrueTrueFalse-
Price Above 200 MATrueTrueTrueTrueFalse-


About : Artivion Inc


Address : 1655 Roberts Boulevard N.W., Kennesaw, GA, United States, 30144
Tel : 770 419 3355
URL : https://artivion.com
Code : AORT, ISIN : US2289031005, Exchange : NYSE, Country : USA
Fiscal Year End : December
IPO date : 12_Feb_1993
Employee Count : 1500

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia.


Note : All Data Generated at the End of Trading Hours (EOD Data)